Clinical Trial Update: Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating reducing heavy drinking to improve HIV treatment and prevention outcomes has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Yale University | Conditions: Reduction in Heavy Drinking in Patients With HIV | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-03-21